Eaton Vance Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $30M | Buy |
|
|||||
|
2022
Q2 | $22.6M | Sell |
|
|||||
|
2022
Q1 | $24.2M | Sell |
|
|||||
|
2021
Q4 | $32.3M | Sell |
|
|||||
|
2021
Q3 | $39.5M | Sell |
|
|||||
|
2021
Q2 | $56.6M | Buy |
|
|||||
|
2021
Q1 | $45.7M | Buy |
|
|||||
|
2020
Q4 | $39.7M | Buy |
|
|||||
|
2020
Q3 | $43.5M | Sell |
|
|||||
|
2020
Q2 | $45.1M | Sell |
|
|||||
|
2020
Q1 | $54.9M | Buy |
|
|||||
|
2019
Q4 | $51.1M | Buy |
|
|||||
|
2019
Q3 | $39.8M | Sell |
|
|||||
|
2019
Q2 | $70.6M | Sell |
|
|||||
|
2019
Q1 | $72.8M | Sell |
|
|||||
|
2018
Q4 | $111M | Sell |
|
|||||
|
2018
Q3 | $159M | Buy |
|
|||||
|
2018
Q2 | $130M | Sell |
|
|||||
|
2018
Q1 | $204M | Buy |
|
|||||
|
2017
Q4 | $137M | Sell |
|
|||||
|
2017
Q3 | $140M | Buy |
|
|||||
|
2017
Q2 | $118M | Sell |
|
|||||
|
2017
Q1 | $126M | Sell |
|
|||||
|
2016
Q4 | $199M | Buy |
|
|||||
|
2016
Q3 | $155M | Buy |
|
|||||
|
2016
Q2 | $105M | Buy |
|
|||||
|
2016
Q1 | $32.9M | Sell |
|
|||||
|
2015
Q4 | $39.8M | Sell |
|
|||||
|
2015
Q3 | $95.9M | Sell |
|
|||||
|
2015
Q2 | $209M | Buy |
|
|||||
|
2015
Q1 | $188M | Buy |
|
|||||
|
2014
Q4 | $137M | Sell |
|
|||||
|
2014
Q3 | $153M | Buy |
|
|||||
|
2014
Q2 | $126M | Buy |
|
|||||
|
2014
Q1 | $99.4M | Buy |
|
|||||
|
2013
Q4 | $59.3M | Buy |
|
|||||
|
2013
Q3 | $26M | Buy |
|
|||||
|
2013
Q2 | $13.1M | Buy |
|